Home-Based Long-Acting Antiretroviral Treatment Offers Safe and Effective HIV Management
Recent research has demonstrated that long-acting injectable antiretroviral therapy (ART) can be administered safely and effectively in a home setting for individuals living with HIV. A study conducted by MUSC Health Infectious Diseases expert Dr. Eric Meissner, published in Clinical Infectious Diseases, found that patients receiving ART injections at home reported high satisfaction levels, comparable to those receiving treatment in clinical settings. The study involved 33 participants choosing between clinic and home administration, with most maintaining their original choice over 12 months. All participants achieved viral suppression, and no serious safety concerns arose in either group.
Typically, long-acting injectable ART given at intervals of two months has been administered exclusively in clinics. However, the study explored the feasibility of at-home treatment, which could significantly improve adherence for patients facing challenges with daily pills or transportation logistics. Dr. Meissner, an associate professor at the Medical University of South Carolina, highlighted that convenience was the primary factor influencing patients’ treatment location choices.
In the study, medications were mailed to patients’ homes, stored in refrigerators, and administered by licensed practical nurses (LPNs). Participants appreciated the consistency of care and the ease of receiving treatment at home. Despite logistical hurdles—such as insurance reimbursement for at-home treatment—the findings suggest that expanding access to home-based injections could enhance adherence and overall health outcomes for many individuals living with HIV.
While current regulations and reimbursement policies pose challenges, the encouraging results support continued efforts to integrate home-based injectable HIV treatment into routine care, offering a safe, feasible, and satisfying option for patients. The study underscores the importance of providing more flexible treatment choices to improve adherence, health outcomes, and quality of life for those managing HIV.
Source: https://medicalxpress.com/news/2025-04-persons-hiv-safely-effectively-antiretroviral.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Understanding Breast Cancer Risks and Outcomes in Aboriginal and Torres Strait Islander Women
This article explores the disparities in breast cancer incidence, diagnosis, and survival outcomes among Aboriginal and Torres Strait Islander women, emphasizing the need for culturally safe healthcare and targeted interventions.
The Potential of Human iPSC-Heart Cells in Fentanyl Opioid Research
Recent studies utilizing human iPSC-derived cardiomyocytes reveal fentanyl’s detrimental effects on heart rhythm, providing new insights into overdose-related cardiac risks and potential for personalized research approaches.
New Research Uncovers How Vaccines Elicit Rapid Lymph Node Responses
New research reveals that vaccines trigger early and rapid responses within lymph nodes, shaping immune activation far sooner than previously understood. Insights into stromal cell changes could improve future vaccine design.
Impact of Air Pollution During Pregnancy on Maternal Metabolism and Premature Birth Risks
Research highlights how air pollution exposure during pregnancy disrupts maternal metabolism, increasing the risk of premature birth and adverse outcomes. Discover the latest findings from Emory University.